HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA appropriations bill passes House

This article was originally published in The Rose Sheet

Executive Summary

The House on Aug. 2 passed its appropriations bill (H.R. 3161), which proposes $1.69 bil. in direct funding for FDA in fiscal 2008. No significant changes affecting FDA were made to the bill sent to the floor by the Agriculture Appropriations Subcommittee (1"The Rose Sheet" July 23, 2007, p. 8). The same day, Sen. Mike Enzi, R-Wyo., asked Majority Leader Harry Reid, D-N.V., to delay naming conferees for the legislation. "If we do this too early, we set ourselves up for the blame game, not for getting this key legislation done," Enzi said. The Senate has not yet passed its corresponding bill (S. 1859)...

You may also be interested in...



House, Senate Appropriations Committees More Than Match Request For FDA

House and Senate appropriators made certain in their recommendations for fiscal 2008 appropriations that FDA would be given opportunity to extend the scope of its oversight, with both houses of Congress more than matching the President's request

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014903

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel